There are no "casualties" here; nothing to be afraid of or apologetic about. We're talking about a .01 difference from being stat.sig. in a trial that's based on subjective reviews. What's important is that the girls have improved while taking the drug... better QOL and a significant reduction in seizures, with NO adverse effects.
Missling will focus on these aspects, perhaps add some biometric data, and advise on next steps with RAs... for both Rett and AD
News 
Market Data 
Discover 
